These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37922591)

  • 21. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DETERMINANT FACTORS OF VISUAL INSPECTION WITH ACETIC ACID (VIA) POSITIVE LESIONS AMONG HIV POSITIVE WOMEN IN MEKELLE HOSPITAL, NORTHERN ETHIOPIA: A CASE CONTROL STUDY.
    Gessesse Z; Tadesse Z; Alemayehu M; Hiruye A; Getachew Y; Derbew M; Mariam DH; Mammo D; Eva K; Yebyo H; Michael HG
    Ethiop Med J; 2015 Jul; Suppl 2():17-24. PubMed ID: 26591279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of abnormal vaginal microflora and HPV infection in cervical precancerous lesions: a retrospective study.
    Yu H; Ma L; Bian M; Li Q; Liang H
    J Infect Dev Ctries; 2022 Jun; 16(6):1089-1095. PubMed ID: 35797305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
    Nang DW; Tukirinawe H; Okello M; Tayebwa B; Theophilus P; Sikakulya FK; Fajardo Y; Afodun AM; Kajabwangu R
    BMC Womens Health; 2023 Apr; 23(1):209. PubMed ID: 37118735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland.
    Jolly PE; Mthethwa-Hleta S; Padilla LA; Pettis J; Winston S; Akinyemiju TF; Turner HJ; Ejiawoko A; Brooks R; Preko L; Preko PO
    BMC Public Health; 2017 Feb; 17(1):218. PubMed ID: 28222714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
    Donkoh ET; Agyemang-Yeboah F; Asmah RH; Wiredu EK
    Medicine (Baltimore); 2019 Mar; 98(13):e14600. PubMed ID: 30921178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical precancerous lesions and cancer among patients in the gynaecology outpatient department at a tertiary hospital in South Africa.
    Hank E; Hoque ME; Zungu L
    Asian Pac J Cancer Prev; 2013; 14(8):4903-6. PubMed ID: 24083765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study.
    Tenkir L; Mamuye A; Jemebere W; Yeheyis T
    Front Glob Womens Health; 2023; 4():1187916. PubMed ID: 37664421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
    Suphattanaporn O; Saraluck A; Mononai J; Lekskul N; Chinthakanan O
    Ann Med; 2023; 55(2):2273428. PubMed ID: 37883921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
    Obol JH; Lin S; Obwolo MJ; Harrison R; Richmond R
    BMC Cancer; 2021 Feb; 21(1):110. PubMed ID: 33535977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors associated with precancerous cervical lesions among women in two cities in Cameroon.
    Wabo B; Nsagha DS; Nana TN; Assob CJN
    Pan Afr Med J; 2022; 41():276. PubMed ID: 35784594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer in the Hauts-Bassins region of Burkina Faso: Results of a screening campaign by visual inspection with acetic acid (VIA screening in Burkina Faso).
    Kagoné TS; Paré PG; Dembélé A; Kania D; Zida S; Bonané/Thiéba B; Ouédraogo A; Testa J; Simporé J; Méda N
    Afr J Reprod Health; 2022 Jun; 26(6):97-103. PubMed ID: 37585062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Cervical Dysplasia in HIV-Positive and HIV-Negative Women at the Sihanouk Hospital Center of HOPE, Phnom Penh , Cambodia.
    Thay S; Peprah SA; Hur C; Tramontano AC; Maling E; Goldstein AT; Hong C
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):653-659. PubMed ID: 30816687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
    Lawson O; Ameyan L; Tukur Z; Dunu S; Kerry M; Okuyemi OO; Yusuf Z; Fasawe O; Wiwa O; Hebert KS; Joseph JT; Nwokwu UE; Okpako O; Chime CI
    BMC Public Health; 2023 Sep; 23(1):1688. PubMed ID: 37658293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study.
    Hu K; Wang J; Sparén P; Herweijer E; Sjölander A; Adami HO; Valdimarsdóttir U; Sundström K; Fang F
    Lancet Public Health; 2023 Apr; 8(4):e266-e275. PubMed ID: 36965981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should cervical cancer screening begin at age 21 for everyone? A quantitative analysis in a high-risk, low-income, African American/Hispanic young-adult population.
    Saeed-Vafa D; Huang Y; Manucha V
    Diagn Cytopathol; 2014 Mar; 42(3):205-12. PubMed ID: 23897742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of cervical cancer screening among underserved women.
    Chankapa YD; Pal R; Tsering D
    Indian J Cancer; 2011; 48(1):40-6. PubMed ID: 21248447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.